ONWARD Medical NV
XBRU:ONWD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of ONWARD Medical NV (ONWD) under the Base Case is EUR per share. Compared with the current market price of 1.39 EUR, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Fundamental Analysis
What ONWARD Medical Does
ONWARD Medical develops implantable and external neurostimulation devices that are designed to help people with spinal cord injury and related movement disorders recover motion and function. Its main products are built around electrical stimulation of the spinal cord, which aims to activate nerve pathways that still exist but no longer work properly after injury. The company focuses on therapies that can support walking, hand use, blood pressure control, and other functions affected by spinal cord damage.
- Headquarters
- Netherlands NL
- Employees
- 137
- IPO date
- Oct 21, 2021
Balance Sheet
Recent Events
Latest Earnings Call
ONWARD paired continued ARC-EX adoption with progress across its ARC-IM pipeline, while reimbursement processes are extending some sales timing.
Open the earnings call- Stock, day of the call
- −11.5%
Past 12 months
Continue ONWD Research
Decided on ONWARD Medical? Get an email when ONWD reaches the price you’d buy at. Free with an account.
Other ONWARD Medical listings
What is the Intrinsic Value of one ONWD stock?
The intrinsic value for ONWARD Medical NV (ONWD) under the Base Case is EUR.
Is ONWD stock undervalued or overvalued?
Compared with the current market price of 1.39 EUR, the stock appears .